Centiva Capital LP lifted its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 16.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC.
The new study in The American Journal of Pathology, published by Elsevier, holds promise to advance personalized ... We don't put up a paywall – we believe in free access to information of public ...
Major Expansion for Morrison Foerster’s Emerging Companies Group In a significant move to strengthen its presence in the competitive market for technology and startup legal services, Morrison Foerster ...
Affinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today reported that the successful execution of its pilot ...
Peterborough police have identified human remains in a decades-old cold case as those of a man who they say was a victim of homicide. Police say recreational divers found ...
An expert on Deinococcus radiodurans, Daly is a professor of pathology at USU and a member of the National Academies' Committee ... When combined with phosphate and manganese, DP1 forms the ...